Sunstein Insights

Back to All Publications

Strategies for Pharmaceutical Portfolio & Product Life-Cycle Management In Face of the New U.S. Patent Law

April 1, 2013

Bruce D. Sunstein

Bruce D. Sunstein | Founder, Partner View more articles

Bruce is a member of our Litigation Practice Group, Patent Practice Group, Trademark Practice Group and Business Practice Group

SMi Pharmaceutical Portfolio and Product Life Cycle Management Conference, London, April 2013.

Most Popular

The Unified Patent Court and Unitary Patent Come to the European Patent Office

by Kathryn E. Noll, Bruce D. Sunstein
COHIBA v. COHIBA: TTAB orders cancellation of the COHIBA registration after a decades long dispute over the well-known trademark

by Odette T. Martins
Watch Me Pull a Customer Out of My Hat: Proving Damages Using Your Customer’s Out-Of-Court Statement

by Bryan D. Harrison
The FTC's Proposed Ban on Non-Compete Agreements: The Effect on Trade Secret Protection

by Jackie Salwa
Facebook Tracking Pixels are the basis for a new wave of privacy class action litigation

by Bryan D. Harrison
AI Machines Continue to Rattle Intellectual Property Law

by Alexander J. Smolenski, Jr.
Supreme Court to Hear the “Bad Spaniels” Case

by Lisa M. Tittemore

Authors

Subscribe to our Newsletters